Business Context and Reporting Period
Company: XpresSpa Group, Inc. (Note: Metadata referenced "XWELL, Inc.", but the filing identifies the registrant as XpresSpa Group, Inc.)
Filing Type: Form 8-K (Current Report)
Date: March 19, 2020
Context: The Company is a Delaware corporation operating in the travel sector. This filing announces a registered direct offering of equity securities, a warrant exchange program, and significant operational impacts due to the coronavirus (COVID-19) outbreak.
Key Financial Metrics and Capital Structure
- Capital Raise: The Company entered into a Securities Purchase Agreement to sell 4,153,383 shares of Common Stock at $0.175 per share and 2,132,333 Pre-Funded Warrants at $0.165 per warrant.
- Gross Proceeds: Approximately $1.1 million (before deducting fees and expenses).
- Advisory Fees: 8% of aggregate gross proceeds payable to Palladium Capital Advisors, LLC, plus reimbursement of legal expenses.
- Cash Position (Preliminary): As of December 31, 2019, the Company reported approximately $2,184,000 in cash, cash equivalents, and marketable securities. Management noted these figures are preliminary and subject to change.
- Debt: The Company has an existing secured lender, B3D, LLC. Additional indebtedness may require B3D's consent and a consent fee.
Material Changes and Operational Impact
The filing discloses a material adverse impact on the Company's business due to the coronavirus outbreak and associated travel restrictions.
- Revenue and Cash Flow: The Company reports a material decline in demand across all locations, resulting in a materially adverse impact on cash flows from operations.
- Liquidity Crisis: Management explicitly states the situation has caused an "immediate liquidity crisis."
- Warrant Exchange: The Company entered into agreements to exchange existing warrants for Common Stock (at a 1.5x ratio) or Pre-Funded Warrants, subject to shareholder approval and Nasdaq rules.
- Strategic Pivot: The Company initiated high-level discussions to convert airport locations in point-of-entry cities into COVID-19 testing facilities.
Outlook, Risks, and Management Commentary
Management's outlook is highly uncertain and contingent on securing additional capital.
- Financing Needs: The Company states it does not have sufficient capital to fund operations in the long term and requires additional financing to continue operations.
- Bankruptcy Risk: If additional funding is not obtained in the immediate term, the Company may be required to curtail or terminate operations. The Board may pursue restructuring, reorganization, bankruptcy, dissolution, or liquidation.
- Investor Risk: Holders of common stock may lose their entire investment in the event of a reorganization, bankruptcy, or liquidation.
- Shareholder Approval: The warrant exchange and certain transactions require shareholder approval. A voting agreement with Mistral Spa Holdings, LLC (holding ~37% of outstanding stock) has been secured to support these proposals.
Key Facts for Investor Verification
- Verify the closing of the $1.1 million registered direct offering and the actual net proceeds after fees.
- Confirm the status of shareholder approval required for the warrant exchange and the increase in authorized shares.
- Monitor the Company's ability to secure additional funding beyond the current offering to avoid immediate cessation of operations.
- Review the final audited financial statements for the year ended December 31, 2019, to confirm the preliminary cash balance of $2.184 million.
- Assess the progress of converting airport locations to COVID-19 testing facilities and any resulting revenue or regulatory approvals.